CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.36, moving -1.26% from the previous trading session.

Citing positive developments in its development programs, analysts from a couple of investment banks think CRISPR Therapeutics(NASDAQ: CRSP) could more than double your money in the year ahead. Start ...

VUG ETF invests in large-cap growth stocks. Check out 3 key reasons why the fund might not be a good choice from a portfolio ...

The Vanguard US Total Market Shares Index ETF (ASX: VTS) outperformed the Vanguard Australian Shares Index ETF (ASX: VAS) by ...

ETFs across various categories pulled in $17.7 billion in capital last week, with U.S. fixed-income ETFs leading the way.

2-Year U.S. Treasury Note Continuous Contract $102.551-0.016-0.02% 5-Year U.S. Treasury Note Continuous Contract $105.445-0.023-0.02% 10-Year U.S. Treasury Note Continuous Contract $107.359 0.000 ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...

Princess Kate Middleton opened up about the side effects of chemo when she visited the Royal Marsden Hospital in London, ...

Fox News correspondent Matt Finn joins 'Special Report' with the latest on lawsuits over the Eaton fire and arrests for ...

Eating a small piece of 70% dark chocolate before bed can help relax your body and keep you warm. Dark chocolate contains ...

Local pastor, father to a four-year-old daughter, and educator fights cancer for the third time. Shreveport/Bossier native ...

A study concluded that the use of over-the-counter pain relievers is more effective than opioids for pain management after ...